When a pharmaceutical company creates a new medication for a chronic illness, like psoriasis, it must maintain the effectiveness and safety of that medication and report adverse events to the U.S. Food and Drug Administration. Instead of collecting the data and developing evidence for the drug itself, however, it might contract with a company like […]